Fig. 1
From: A long non-coding RNA signature to improve prognosis prediction of gastric cancer
Kaplan-Meier estimates of the disease free survival (DFS) or overall survival (OS) of GEO patients using the 24-lncRNA signature. The Kaplan-Meier plots were used to visualize the DFS probabilities for the low-risk versus high-risk group of patients based on the median risk score from corresponding GEO datasets patents. a Kaplan-Meier curves for GSE62254 test series patients (N = 180); (b) Kaplan-Meier curves for GSE62254 validation series patients (N = 120); (c) Kaplan-Meier curves for the entire GSE62254 series patients (combined test and validation series patients, N = 300). d Kaplan-Meier curves for GSE15459 patients (N = 192). The tick marks on the Kaplan-Meier curves represent the censored subjects. The differences between the two curves were determined by the two-side log-rank test